[ASC-list] FW: AIBN Seminar: Associate Professor Gordon Xu, Associate AIBN Group Leader

[Jayne Keane]

AIBN SEMINAR SERIES 2012:

 

Presenter:

Associate Professor Gordon Xu, Associate AIBN Group Leader

Title:

Biomedical Applications of Layered Double Hydroxide Nanoparticles 

Date:

Friday, 12 October 2012

Time:

12:00pm

Venue:

Physiology Lecture Theatres (Building 63) - Lecture Theatre 360

 

Abstract:  Layered double hydroxides (LDHs), also known as anionic
clays, find a high potential in nanomedicinal application as the
drug/gene delivery vehicle. These nanomaterials show a number of
advantages over the counter-part organic ones, such as easy preparation
in lab at low cost, precise control in particle size, low cytotoxicity,
good biocompatibility, and high endosomal escapability. We have
developed a robust way to control prepare LDH nanoaprticles (NPs) with
the particle size of 30-300 nm in a stable homogeneous suspension. 

 

We have first found that LDH NPs can be quickly taken up by various cell
lines, in a clathrin-mediated dose-dependent and time-dependent
endocytosis pathway. More excitedly, we have for the first time
discovered that the rod-like LDH NPs are mostly located in the nucleus
while plate-like LDH NPs in the perinuclear area, which may imply a
strategy that can be used to target the subcellular compartments by
controlling the shape/size of delivery vehicles. 

 

We have then found that LDH NPs can deliver supercoiled plasmid DNA (ca.
6.1k bps) into various cell lines with a transfection efficacy up to
70-80% cells in the optimized conditions.  Moreover, LDH NPs are able to
siRNA into CHO cells to knockdown the expression of the target protein
with the efficiency compared with the commercial delivery vehicle. We
have shown that cultured neurons can more efficiently internalize
siRNA-LDH NPs than non-neuronal cells (eg. fibroblasts), and that
release of siRNA into the neuronal cytoplasm resulted in knockdown of
the axon guidance receptor DCC.

 

We have also found that LDH NPs are able to deliver anti-restenotic
drug, low molecular weight heparin (LMWH) to vascular smooth muscle
cells (SMCs). Intercalation of LMWH into LDH enables the release to
sustain for over 5 days. LMWH-LDH nanohybrids enhance the inhibition to
SMC proliferation and migration by ~60% compared with the control, e.g.
promoting the biological functions of LMWH on SMCs, which is actively
pursued for anti-restenosis treatment.

 

Very recently, we have found for the first time that LDH can be used as
a good antigen carrier for effective promotion of the antibody response.
The activity of LDH nanoparticles is even higher than the commonly used
adjuvant QuilA. More works are underway.

 


******************* Disclaimer *******************
The contents of this electronic message and any attachments are intended only for the addressee and may contain privileged or confidential information. 
They may only be used for the purposes for which they were supplied.
If you are not the addressee, you are notified that any transmission, distribution, downloading, printing or photocopying of the contents of this message 
or attachments is strictly prohibited. 
The privilege of confidentiality attached to this message and attachments is not waived, lost or destroyed by reason of mistaken delivery to you. 
If you receive this message in error please notify the sender by return e-mail or telephone. 
Please note: the Queensland Museum carries out automatic software scanning, filtering and blocking of E-mails and
attachments (including emails of a personal nature) for detection of viruses, malicious code, SPAM, executable programs or content it deems unacceptable. 
All reasonable precautions will be taken to respect the privacy of individuals as outlined in the QM Privacy Plan. 
Personal information will only be used for official purposes, e.g. monitoring Departmental Personnel's compliance with Museum Policies. 
Personal information will not be divulged or disclosed to others, unless as required by Museum Policy and/or State or Commonwealth Law.
******************** Disclaimer *******************


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://www.lists.sublimeip.com/pipermail/asc-list/attachments/20121009/b1b5dfa6/attachment.htm>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.gif
Type: image/gif
Size: 3924 bytes
Desc: image002.gif
URL: <https://www.lists.sublimeip.com/pipermail/asc-list/attachments/20121009/b1b5dfa6/attachment.gif>